ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,297Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 107

$1.24M Total Retail Price of All Prescriptions

Rank: 1 out of 107

319 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 6,896 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

60% of this provider’s prescriptions were for brand-name drugs, compared to an average of 47%.

Prescription Price

$170 was the average price of a prescription from this provider, compared to $159 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
JANUMET 598 594 1 18
PRANDIN 416 413 10 2 30
LEVOTHYROXINE SODIUM 344 333 3 1
ACTOS 246 224 4 25
LANTUS SOLOSTAR 229 205 5 4
METFORMIN HCL 221 189 6 2
JANUVIA 217 214 7 14
NOVOLOG FLEXPEN 192 180 8 12
VICTOZA 3-PAK 189 166 9 28
ACTONEL 186 186 10 44
SIMVASTATIN 177 162 11 7
PRAVASTATIN SODIUM 170 170 12 26
METHIMAZOLE 156 151 13 17
ATORVASTATIN CALCIUM 153 150 14 15
METFORMIN HCL ER 136 123 15 11
PEN NEEDLES 131 115 10 16 53
AMLODIPINE BESYLATE-BENAZEPRIL 115 103 17 59
PEN NEEDLE 114 106 18 3
SYNTHROID 108 99 19 5
LANTUS 94 85 20 6
HYDROCHLOROTHIAZIDE 93 93 21 22
AMLODIPINE BESYLATE 88 82 22 16
GABAPENTIN 87 85 23 38
BYETTA 87 74 23 50
CYMBALTA 83 83 25 71
VICTOZA 2-PAK 81 69 26 72
DIOVAN HCT 75 75 27 34
ATELVIA 75 72 27 75
DIOVAN 71 71 29 42
ALENDRONATE SODIUM 71 71 29 29
CRESTOR 63 47 31 26
FELODIPINE ER 59 59 32 87
ZETIA 58 58 33 47
INSULIN SYRINGE 58 51 33 13
PIOGLITAZONE HCL 53 45 R 35 60
NATEGLINIDE 52 52 36 58
GLUMETZA 51 51 37 98
GLIPIZIDE XL 50 50 38 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.